bioAffinity Technologies annual current ratio
2021
2022
2023
2024
2025
bioAffinity Technologies Current Ratio Growth & History (BIAF)
bioAffinity Technologies's current ratio was 2.60 for fiscal 2025.
View full bioAffinity Technologies company overviewbioAffinity Technologies annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.60 | 1.74 | +199.90% |
| 2024 | 2024-12-31 | 0.87 | −0.90 | −50.89% |
| 2023 | 2023-12-31 | 1.77 | −8.74 | −83.18% |
| 2022 | 2022-12-31 | 10.50 | 10.39 | +9424.07% |
| 2021 | 2021-12-31 | 0.11 | — | — |
bioAffinity Technologies quarterly current ratio
Q4.21
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.44 | 0.80 | +123.62% |
| Q1 2026 | 2026-03-31 | 1.36 | 0.82 | +149.79% |
| Q4 2025 | 2025-12-31 | 2.60 | 1.74 | +199.90% |
| Q3 2025 | 2025-09-30 | 3.65 | 2.63 | +256.75% |
| Q2 2025 | 2025-06-30 | 0.64 | −0.51 | −44.04% |
| Q1 2025 | 2025-03-31 | 0.55 | −1.67 | −75.41% |
| Q4 2024 | 2024-12-31 | 0.87 | −0.90 | −50.89% |
| Q3 2024 | 2024-09-30 | 1.02 | −2.05 | −66.65% |
| Q2 2024 | 2024-06-30 | 1.15 | −10.02 | −89.69% |
| Q1 2024 | 2024-03-31 | 2.22 | −10.63 | −82.73% |
| Q4 2023 | 2023-12-31 | 1.77 | −8.74 | −83.18% |
| Q3 2023 | 2023-09-30 | 3.07 | −6.53 | −68.03% |
| Q2 2023 | 2023-06-30 | 11.17 | — | — |
| Q1 2023 | 2023-03-31 | 12.85 | — | — |
| Q4 2022 | 2022-12-31 | 10.50 | 10.39 | +9424.07% |
| Q3 2022 | 2022-09-30 | 9.60 | — | — |
| Q4 2021 | 2021-12-31 | 0.11 | — | — |
bioAffinity Technologies current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, bioAffinity Technologies's current ratio increased from 0.11 to 2.60, a change of 2.49. The latest reported quarter, Q2 2026, shows 1.44.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review bioAffinity Technologies source filings ↗